The smart Trick of wegovy injection availability That No One is Discussing
In the first section III reports in the initial 3 months write-up-transplantation, 14% of individuals while in the basiliximab team and 27% of individuals while in the placebo team experienced an acute rejection episode treated with antibody therapy (OKT 3 or antithymocyte globulin/antilymphocyte globulin [ATG/ALG]), with no increase in adverse act